Anti-A. niger polyclonal antibody

Aspergillus niger exists as a filamentous ascomycete fungus throughout natural environments and belongs to the eukaryotic classification. A. niger conidial heads display a radial arrangement with dark brown coloration and include spherical vesicles and biseriate sterigmata. A. niger exists in grains together with plant materials and soil. The fungal colonies start off white but darken to a brown hue during conidia maturation and the underside remains colorless or pale yellow. A. niger demonstrates rapid growth on Czapek agar medium and develops colonies that measure between 2.5 and 3 cm in diameter while exhibiting a velvety texture.

A. niger functions as a crucial fermentation strain in industrial processes which produce organic acids and enzymes and promotes biotechnological progress. Many industrial products rely on primary and secondary metabolites derived from filamentous fungi for their production. A complex metabolic network supports A. niger to release more than 50 hydrolytic enzymes such as amylases and proteases while producing citric acid efficiently through concurrent growth and saccharification processes. Research demonstrates A. niger's ability to break down complex organic materials such as lignocellulose and tannins while also showing resistance to both elevated temperatures up to 45°C and hyperosmotic conditions. Industrially, it dominates citric acid production globally. Its secreted enzymes—such as glucose oxidase and glucoamylase—are widely used in food processing; for example, reducing diacetyl content in beer brewing to enhance product stability. A. niger plays a vital role in the creation of soy sauce and vinegar products by breaking down starch and proteins which develops special flavors during traditional fermentation processes.

Figure 1. Production of citric acid by A. niger
(Source: Behera BC. 2020)

Aspergillus niger is utilized in the medical field for producing acid proteases used in digestive agent preparation and tannase to catalyze gallic acid synthesis, the latter being a key intermediate in antitumor drugs. Certain strains produce toxins such as ochratoxin A (OTA) and fumonisin B2 (FB2), making genetic screening essential for ensuring production strain safety. Research indicates that immunocompromised patients who inhale spores face a risk of invasive pulmonary aspergillosis while A. niger accounts for 30% of otomycosis infections. Research shows that A. niger possesses genetic traits which enable it to adapt to various environments but still has around 30% of its gene functions that scientists have not identified. Current challenges include: The development of fast detection technologies for toxic strains remains essential alongside the enhancement of genetic tool efficiency through RNP-based CRISPR systems that address traditional transformation efficiency problems together with the use of multi-omics data integration to improve fermentation processes by employing metabolic network models. Advancements in synthetic biology technologies will create new opportunities for A. niger applications in fields such as biomaterials and environmental remediation.

Anti-Aspergillus niger polyclonal antibody